| |
Training Set
|
Validation Set
|
P
T-V
|
|---|
| |
MCD
|
FSGS
|
P
|
MCD
|
FSGS
|
P
|
MCD
|
FSGS
|
|---|
|
No. of subjects
|
10
|
11
| |
14
|
14
| | | |
|
Age (years)
|
39.5 (28.0 –68.0)
|
57.0 (31.0 –71.0)
|
0.57
|
55.5 (30.0 –72.0)
|
54.5 (36.0 –59.0)
|
0.45
|
0.32
|
0.85
|
|
Female/male ratio
|
3/7
|
5/6
|
0.47
|
6/8
|
2/12
|
0.09
|
0.52
|
0.08
|
|
Body mass index (kg/m2)
|
27.3 (21.9 –33.8)
|
25.5 (24.0 –26.6)
|
0.68
|
29.4 (24.2 –30.6)
|
26.3 (25.1 –28.4)
|
0.63
|
0.76
|
0.41
|
|
Body surface area
|
1.7 (1.7 –1. 9)
|
1.8 (1.6 –1.8)
|
0.83
|
1.8 (1.6 –1.9)
|
1.9 (1.8 –2.0)
|
0.35
|
0.52
|
0.11
|
|
Serum glucose (mg/dl)
|
91 (81–101)
|
88 (83–97)
|
0.89
|
84 (81–94)
|
94 (87–97)
|
0.19
|
0.44
|
0.67
|
|
Serum protein (g/dl)
|
4.4 (3.7 –4.7)
|
5.0 (4.1 –6.2)
|
0.09
|
4.7 (4.1 –4.9)
|
6.1 (4.5 –6.3)
|
0.05
|
0.29
|
0.56
|
|
Serum creatinine (mg/dl)
|
0.9 (0.8 –1.0)
|
1.2 (0.9 –1.2)
|
0.12
|
0.9 (0.8 –1.3)
|
1.3 (0.9 –1.8)
|
0.24
|
0.64
|
0.62
|
|
Proteinuria (g/24 h)
|
10.6 (2.3 –12.2)
|
3.5 (2.5 –7.4)
|
0.29
|
9.7 (5.9 –15.0)
|
3.4 (1.7 –4.5)
|
0.004
|
0.52
|
0.64
|
- Data are shown as median (interquartile range)
- Differences between groups were tested using the non-parametric Kruskall Wallis test. P
T-V shows P value between training and validation set. P < 0.05 was considered significant
